Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
20.74
-0.56 (-2.63%)
At close: Sep 22, 2026, 4:00 PM EDT
20.83
+0.09 (0.43%)
After-hours: Sep 22, 2026, 4:10 PM EDT
Attovia Therapeutics Market Cap
Attovia Therapeutics has a market cap or net worth of $946.81 million as of September 22, 2026.
Market Cap
946.81M
Enterprise Value
836.00M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.74
ChartMarket Cap Chart
Since the IPO on August 5, 2026, Attovia Therapeutics's market cap has increased from $731.49M to $946.81M, an increase of 29.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 946.81M | -2.63% |
| Sep 21, 2026 | 972.37M | -3.79% |
| Sep 18, 2026 | 1.01B | -2.60% |
| Sep 17, 2026 | 1.04B | 2.16% |
| Sep 16, 2026 | 1.02B | -6.12% |
| Sep 15, 2026 | 1.08B | -3.34% |
| Sep 14, 2026 | 1.12B | 7.59% |
| Sep 11, 2026 | 1.04B | 1.15% |
| Sep 10, 2026 | 1.03B | -1.44% |
| Sep 9, 2026 | 1.04B | -3.38% |
| Sep 8, 2026 | 1.08B | -7.40% |
| Sep 4, 2026 | 1.17B | 5.58% |
| Sep 3, 2026 | 1.10B | 4.63% |
| Sep 2, 2026 | 1.06B | 10.44% |
| Sep 1, 2026 | 956.10M | 3.83% |
| Aug 31, 2026 | 920.82M | 3.38% |
| Aug 28, 2026 | 890.70M | -3.54% |
| Aug 27, 2026 | 923.40M | 9.77% |
| Aug 26, 2026 | 841.22M | 1.24% |
| Aug 25, 2026 | 830.89M | -6.35% |
| Aug 24, 2026 | 887.26M | -0.87% |
| Aug 21, 2026 | 895.00M | 2.92% |
| Aug 20, 2026 | 869.62M | -8.72% |
| Aug 19, 2026 | 952.66M | -4.73% |
| Aug 18, 2026 | 999.99M | 2.33% |
| Aug 17, 2026 | 977.19M | 14.35% |
| Aug 14, 2026 | 854.56M | 3.55% |
| Aug 13, 2026 | 825.30M | 6.20% |
| Aug 12, 2026 | 777.10M | -3.16% |
| Aug 11, 2026 | 802.49M | -6.00% |
| Aug 10, 2026 | 853.70M | -1.64% |
| Aug 7, 2026 | 867.90M | -1.03% |
| Aug 6, 2026 | 876.93M | 19.88% |
| Aug 5, 2026 | 731.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.06B |
| MoonLake Immunotherapeutics | 1.05B |
| Kura Oncology | 1.04B |
| Monte Rosa Therapeutics | 1.03B |
| Janux Therapeutics | 1.01B |
| Adlai Nortye Group | 1.01B |
| Alumis | 1.01B |
| Arbutus Biopharma | 991.22M |